China Resources Jiangzhong Pharmaceutical Co.,Ltd (SHA:600750)
China flag China · Delayed Price · Currency is CNY
23.21
0.00 (0.00%)
Nov 6, 2026, 3:00 PM CST

SHA:600750 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
840.55906.69788.19718.67598.24505.69
Depreciation & Amortization
148.08148.08136.81126122115.44
Other Amortization
4.244.240.940.860.450.3
Loss (Gain) From Sale of Assets
-0.61-0.61-1.84-1.220.13-0.9
Asset Writedown & Restructuring Costs
0.680.681.052.04--
Loss (Gain) From Sale of Investments
-0.59-0.599.640.05-61.47-51.25
Provision & Write-off of Bad Debts
-0.48-0.488.67-0.341.34-0.31
Other Operating Activities
95.881.72-7.9615.8734.6516.69
Change in Accounts Receivable
256.19256.19-326.87257.899.75159.5
Change in Inventory
9.779.7710.82-50-3.3-23.63
Change in Accounts Payable
-372.51-372.51175.97-65.85309.96200.5
Change in Other Net Operating Assets
15.2415.243.638.9410.661.19
Operating Cash Flow
998.9970.87786.251,0391,022917.04
Operating Cash Flow Growth
-21.54%23.48%-24.36%1.73%11.42%21.87%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-228.67-280.57-290.77-211.15-345.73-188.49
Sale of Property, Plant & Equipment
0.060.113.890.250.051.24
Cash Acquisitions
-41.85-48.85---197.89
Investment in Securities
-364.24-144.65234.9339.68370.87-1,308
Other Investing Activities
121.2247.65122.9156.6543.4860.98
Investing Cash Flow
-513.48-426.3380.97-114.5868.67-1,237

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-227.64--30-
Total Debt Issued
235.41227.64--30-
Short-Term Debt Repaid
-----30-
Long-Term Debt Repaid
--1.37-1.55-1.95-2.17-0.8
Lease Payments
-1.37-1.37-1.55-1.95-2.17-0.8
Total Debt Repaid
-1.37-1.37-1.55-1.95-32.17-0.8
Net Debt Issued (Repaid)
234.04226.27-1.55-1.95-2.17-0.8
Issuance of Common Stock
9.0483.95--8.8937.96
Repurchase of Common Stock
-0.57-0.57-1.31-1.12-2.32-73.27
Common Dividends Paid
-1,212-777.95-768.46-816.52-733.1-313.37
Other Financing Activities
0.02-19.11-86.12-13.48--
Financing Cash Flow
-969.09-487.41-857.44-833.07-728.7-349.48

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-483.6757.139.7891.82361.72-669.02

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
770.23690.29495.49828.31676.02728.55
Free Cash Flow Growth
-19.28%39.32%-40.18%22.53%-7.21%27.82%
Free Cash Flow Margin
19.51%16.36%11.17%18.19%17.40%25.35%
Free Cash Flow Per Share
1.221.090.791.151.071.15
Levered Free Cash Flow
-505.67742.34253.67541.68517.63862.86
Unlevered Free Cash Flow
-504.2743.47254.74546.04520.37865.02
Free Cash Flow After Leases
768.86688.93493.94826.37673.85727.74

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
551.19605.96532.47485.59421.79392.17
Change in Working Capital
-88.85-88.85-149.22137.54326.4331.38